A Decisive Decade for Cardiovascular Health in Africa: Turning Evidence into System Design

Johann A C Edjimbi1,2,3, Mohamed B Jalloh1, Krutarth Kandarp Pandya4

  • 1Alliance for Medical Research in Africa (AMedRA), Dakar, Senegal.

Global Heart
|May 4, 2026
PubMed

Insights

Cardiovascular disease is a growing threat in Africa, but effective prevention and management are possible. Reforming health systems to prioritize chronic care can save millions of lives.

Area of Science:

  • Public Health
  • Cardiology
  • Health Systems Strengthening

Background:

  • Cardiovascular disease (CVD) is a leading cause of premature death in Africa, outpacing current healthcare capacities.
  • The existing healthcare infrastructure is ill-equipped for chronic disease management, leading to late-stage interventions for conditions like heart failure and stroke.
  • Despite challenges, successful CVD care models exist in several African nations, emphasizing primary and district-level facilities.

Purpose of the Study:

  • To highlight the escalating burden of cardiovascular disease in Africa.
  • To advocate for health system redesign to effectively manage chronic cardiovascular conditions.
  • To emphasize the potential for preventing millions of deaths through strategic interventions.

Main Methods:

  • Analysis of current trends in cardiovascular disease mortality across Africa.
  • Review of successful primary and district-level healthcare models for CVD management.
  • Examination of global health system reforms (e.g., Brazil, Thailand) for lessons applicable to Africa.
  • Assessment of strategies for integrating CVD care into universal health coverage.

Main Results:

  • Cardiovascular disease mortality is rising rapidly, exceeding prevention and management capabilities.
  • Effective, scalable cardiovascular care is achievable through primary and district health facilities.
  • Strategic health system design is crucial for population-level improvements in cardiovascular health.

Conclusions:

  • Africa is at a critical juncture to address the rising tide of cardiovascular disease.
  • Integrating CVD prevention and treatment into universal health coverage strategies is essential.
  • Aligning financing and service delivery with chronic care needs can avert millions of premature deaths.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
5.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K